

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.92980506 |
| 2 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.81338640 |
| 3 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.31683229 |
| 4 | ATP synthesis coupled proton transport (GO:0015986) | 5.31683229 |
| 5 | respiratory electron transport chain (GO:0022904) | 5.15575496 |
| 6 | electron transport chain (GO:0022900) | 5.04296023 |
| 7 | chaperone-mediated protein transport (GO:0072321) | 4.80406671 |
| 8 | fatty acid elongation (GO:0030497) | 4.54669892 |
| 9 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.36919748 |
| 10 | protein complex biogenesis (GO:0070271) | 4.21445839 |
| 11 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.12876696 |
| 12 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.12876696 |
| 13 | NADH dehydrogenase complex assembly (GO:0010257) | 4.12876696 |
| 14 | mitochondrial calcium ion transport (GO:0006851) | 3.98577931 |
| 15 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.85682832 |
| 16 | purine ribonucleotide transport (GO:0015868) | 3.77151066 |
| 17 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.71028109 |
| 18 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.60643964 |
| 19 | adenine nucleotide transport (GO:0051503) | 3.52630925 |
| 20 | NADH metabolic process (GO:0006734) | 3.52485431 |
| 21 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.50820539 |
| 22 | L-phenylalanine catabolic process (GO:0006559) | 3.50820539 |
| 23 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.46608918 |
| 24 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.46608918 |
| 25 | peroxisome fission (GO:0016559) | 3.40893359 |
| 26 | succinate metabolic process (GO:0006105) | 3.38839144 |
| 27 | * hydrogen ion transmembrane transport (GO:1902600) | 3.35010331 |
| 28 | inner mitochondrial membrane organization (GO:0007007) | 3.34012750 |
| 29 | regulation of oxidative phosphorylation (GO:0002082) | 3.32992650 |
| 30 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.31159124 |
| 31 | L-phenylalanine metabolic process (GO:0006558) | 3.31159124 |
| 32 | NIK/NF-kappaB signaling (GO:0038061) | 3.29300683 |
| 33 | deoxyribonucleotide catabolic process (GO:0009264) | 3.24196837 |
| 34 | protein neddylation (GO:0045116) | 3.23719976 |
| 35 | nuclear envelope reassembly (GO:0031468) | 3.19979843 |
| 36 | mitotic nuclear envelope reassembly (GO:0007084) | 3.19979843 |
| 37 | * respiratory chain complex IV assembly (GO:0008535) | 3.15815375 |
| 38 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.14514341 |
| 39 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.14514341 |
| 40 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.14276630 |
| 41 | purine nucleotide transport (GO:0015865) | 3.14206745 |
| 42 | * ATP biosynthetic process (GO:0006754) | 3.11806720 |
| 43 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.09868845 |
| 44 | aldehyde catabolic process (GO:0046185) | 3.08882196 |
| 45 | * proton transport (GO:0015992) | 3.04773166 |
| 46 | sulfur amino acid catabolic process (GO:0000098) | 3.03414950 |
| 47 | coenzyme catabolic process (GO:0009109) | 3.02433467 |
| 48 | deoxyribose phosphate catabolic process (GO:0046386) | 3.02291244 |
| 49 | * hydrogen transport (GO:0006818) | 3.00910422 |
| 50 | * oxidative phosphorylation (GO:0006119) | 2.97871699 |
| 51 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.94447020 |
| 52 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.94188026 |
| 53 | viral protein processing (GO:0019082) | 2.91489055 |
| 54 | oxaloacetate metabolic process (GO:0006107) | 2.90954105 |
| 55 | mannosylation (GO:0097502) | 2.90147269 |
| 56 | * purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.87382833 |
| 57 | dopamine transport (GO:0015872) | 2.86621517 |
| 58 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.86504536 |
| 59 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.86118840 |
| 60 | * purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.84560452 |
| 61 | * cytochrome complex assembly (GO:0017004) | 2.82919002 |
| 62 | rRNA modification (GO:0000154) | 2.82656558 |
| 63 | protein maturation by protein folding (GO:0022417) | 2.80699662 |
| 64 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.80659041 |
| 65 | cellular ketone body metabolic process (GO:0046950) | 2.80474152 |
| 66 | regulation of cellular respiration (GO:0043457) | 2.79510501 |
| 67 | DNA deamination (GO:0045006) | 2.78262453 |
| 68 | transferrin transport (GO:0033572) | 2.78176777 |
| 69 | iron-sulfur cluster assembly (GO:0016226) | 2.75595252 |
| 70 | metallo-sulfur cluster assembly (GO:0031163) | 2.75595252 |
| 71 | neutrophil activation involved in immune response (GO:0002283) | 2.72664308 |
| 72 | nucleoside transport (GO:0015858) | 2.72412786 |
| 73 | cofactor catabolic process (GO:0051187) | 2.71122102 |
| 74 | amino acid salvage (GO:0043102) | 2.70896264 |
| 75 | L-methionine salvage (GO:0071267) | 2.70896264 |
| 76 | L-methionine biosynthetic process (GO:0071265) | 2.70896264 |
| 77 | * aerobic respiration (GO:0009060) | 2.68483426 |
| 78 | central nervous system myelination (GO:0022010) | 2.67379757 |
| 79 | axon ensheathment in central nervous system (GO:0032291) | 2.67379757 |
| 80 | aromatic amino acid family catabolic process (GO:0009074) | 2.67223362 |
| 81 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.65730163 |
| 82 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.64261829 |
| 83 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.64107572 |
| 84 | base-excision repair, AP site formation (GO:0006285) | 2.63683690 |
| 85 | neuronal action potential propagation (GO:0019227) | 2.63337690 |
| 86 | xenobiotic catabolic process (GO:0042178) | 2.63324007 |
| 87 | thioester biosynthetic process (GO:0035384) | 2.61098870 |
| 88 | acyl-CoA biosynthetic process (GO:0071616) | 2.61098870 |
| 89 | regulation of mitochondrial translation (GO:0070129) | 2.60670635 |
| 90 | amino sugar catabolic process (GO:0046348) | 2.59989012 |
| 91 | synaptic vesicle exocytosis (GO:0016079) | 2.59520907 |
| 92 | deoxyribose phosphate metabolic process (GO:0019692) | 2.59039668 |
| 93 | glutathione biosynthetic process (GO:0006750) | 2.58506001 |
| 94 | presynaptic membrane assembly (GO:0097105) | 2.57917600 |
| 95 | presynaptic membrane organization (GO:0097090) | 2.57451160 |
| 96 | proteasome assembly (GO:0043248) | 2.56594675 |
| 97 | positive regulation of mitochondrial fission (GO:0090141) | 2.56349612 |
| 98 | trivalent inorganic cation transport (GO:0072512) | 2.56263181 |
| 99 | ferric iron transport (GO:0015682) | 2.56263181 |
| 100 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.55819916 |
| 101 | NAD metabolic process (GO:0019674) | 2.55744033 |
| 102 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.55531004 |
| 103 | response to thyroid hormone (GO:0097066) | 2.54959406 |
| 104 | thioester metabolic process (GO:0035383) | 2.54845242 |
| 105 | acyl-CoA metabolic process (GO:0006637) | 2.54845242 |
| 106 | neurotransmitter uptake (GO:0001504) | 2.53501968 |
| 107 | intracellular protein transmembrane import (GO:0044743) | 2.51265731 |
| 108 | branched-chain amino acid catabolic process (GO:0009083) | 2.51034573 |
| 109 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.50447347 |
| 110 | very long-chain fatty acid metabolic process (GO:0000038) | 2.50197832 |
| 111 | virion assembly (GO:0019068) | 2.50193291 |
| 112 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.50147453 |
| 113 | tricarboxylic acid cycle (GO:0006099) | 2.49788185 |
| 114 | purine ribonucleoside diphosphate metabolic process (GO:0009179) | 2.49460575 |
| 115 | purine nucleoside diphosphate metabolic process (GO:0009135) | 2.49460575 |
| 116 | signal peptide processing (GO:0006465) | 2.49283287 |
| 117 | * ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.48781867 |
| 118 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.48314365 |
| 119 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.48242542 |
| 120 | regulation of autophagic vacuole assembly (GO:2000785) | 2.45951767 |
| 121 | immunoglobulin mediated immune response (GO:0016064) | 2.42723217 |
| 122 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.42675847 |
| 123 | ketone body metabolic process (GO:1902224) | 2.41655105 |
| 124 | substantia nigra development (GO:0021762) | 2.41651188 |
| 125 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.41208158 |
| 126 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.40267841 |
| 127 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.40234336 |
| 128 | regulation of dopamine metabolic process (GO:0042053) | 2.38566871 |
| 129 | regulation of catecholamine metabolic process (GO:0042069) | 2.38566871 |
| 130 | phagosome maturation (GO:0090382) | 2.38284721 |
| 131 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.38132067 |
| 132 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.37779555 |
| 133 | GDP-mannose metabolic process (GO:0019673) | 2.36901310 |
| 134 | heme metabolic process (GO:0042168) | 2.36676601 |
| 135 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.34993815 |
| 136 | dicarboxylic acid catabolic process (GO:0043649) | 2.34922677 |
| 137 | bile acid biosynthetic process (GO:0006699) | 2.34290495 |
| 138 | mitochondrial transport (GO:0006839) | 2.33660931 |
| 139 | valine metabolic process (GO:0006573) | 2.33211575 |
| 140 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.32744221 |
| 141 | protein deneddylation (GO:0000338) | 2.30960079 |
| 142 | protein targeting to mitochondrion (GO:0006626) | 2.30666889 |
| 143 | cholesterol biosynthetic process (GO:0006695) | 2.30583332 |
| 144 | amyloid precursor protein catabolic process (GO:0042987) | 2.30121779 |
| 145 | glutathione derivative biosynthetic process (GO:1901687) | 2.30043277 |
| 146 | glutathione derivative metabolic process (GO:1901685) | 2.30043277 |
| 147 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.29800199 |
| 148 | response to peptidoglycan (GO:0032494) | 2.29615756 |
| 149 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.29455794 |
| 150 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.29455794 |
| 151 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.29292664 |
| 152 | pentose metabolic process (GO:0019321) | 2.29235432 |
| 153 | neuron cell-cell adhesion (GO:0007158) | 2.28836584 |
| 154 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.28826209 |
| 155 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.28300454 |
| 156 | establishment of protein localization to mitochondrion (GO:0072655) | 2.26725156 |
| 157 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.26608981 |
| 158 | modulation by symbiont of host immune response (GO:0052553) | 2.26608981 |
| 159 | positive regulation by symbiont of host defense response (GO:0052509) | 2.26608981 |
| 160 | modulation by symbiont of host defense response (GO:0052031) | 2.26608981 |
| 161 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.26608981 |
| 162 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.26608981 |
| 163 | cullin deneddylation (GO:0010388) | 2.25926250 |
| 164 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.25480437 |
| 165 | regulation of vacuole organization (GO:0044088) | 2.25305408 |
| 166 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.24849591 |
| 167 | negative regulation of cell killing (GO:0031342) | 2.24849591 |
| 168 | GMP metabolic process (GO:0046037) | 2.24604721 |
| 169 | glutathione metabolic process (GO:0006749) | 2.24002830 |
| 170 | glyoxylate metabolic process (GO:0046487) | 2.20030627 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.25157730 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.13771911 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.09475196 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.06948462 |
| 5 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.87057470 |
| 6 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.77496968 |
| 7 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.63511544 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.61652923 |
| 9 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.58607964 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.45809097 |
| 11 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.37034117 |
| 12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.34972571 |
| 13 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.32041094 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.30036584 |
| 15 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.29729150 |
| 16 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.26543715 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.24440186 |
| 18 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.16479811 |
| 19 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.16361342 |
| 20 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.09151761 |
| 21 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.01827815 |
| 22 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.98966989 |
| 23 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.96409067 |
| 24 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.95120829 |
| 25 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93274092 |
| 26 | P68_20966046_ChIP-Seq_HELA_Human | 1.89789482 |
| 27 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.88312393 |
| 28 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.85762792 |
| 29 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.85649431 |
| 30 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.84125250 |
| 31 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.81063442 |
| 32 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.78135788 |
| 33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78085345 |
| 34 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.76119861 |
| 35 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.73097109 |
| 36 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.71149624 |
| 37 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.70430785 |
| 38 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.69679443 |
| 39 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.67741492 |
| 40 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.67577759 |
| 41 | MAF_26560356_Chip-Seq_TH2_Human | 1.65837400 |
| 42 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.63590096 |
| 43 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.59891961 |
| 44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.55972183 |
| 45 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.55431871 |
| 46 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.55072187 |
| 47 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.54475446 |
| 48 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.54090039 |
| 49 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.54012474 |
| 50 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.53898744 |
| 51 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.53631811 |
| 52 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.51177051 |
| 53 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.48175358 |
| 54 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.45833185 |
| 55 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.44162486 |
| 56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42110654 |
| 57 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41578402 |
| 58 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.41278051 |
| 59 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.39752864 |
| 60 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.39224665 |
| 61 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.38761131 |
| 62 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.38265404 |
| 63 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38210138 |
| 64 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.37856213 |
| 65 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.37637415 |
| 66 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.37194911 |
| 67 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.34553020 |
| 68 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.34096173 |
| 69 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33566109 |
| 70 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.32714778 |
| 71 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32640795 |
| 72 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.31942803 |
| 73 | SA1_27219007_Chip-Seq_Bcells_Human | 1.31772365 |
| 74 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.29728932 |
| 75 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.29628968 |
| 76 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.29225955 |
| 77 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.27784042 |
| 78 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.27677552 |
| 79 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27373978 |
| 80 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.26090596 |
| 81 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.25310511 |
| 82 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.25247727 |
| 83 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.25163102 |
| 84 | P300_27268052_Chip-Seq_Bcells_Human | 1.25023776 |
| 85 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.24348943 |
| 86 | MAF_26560356_Chip-Seq_TH1_Human | 1.23578533 |
| 87 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.21161951 |
| 88 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.20817158 |
| 89 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.20635093 |
| 90 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.20510376 |
| 91 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20141240 |
| 92 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.19753271 |
| 93 | UTX_26944678_Chip-Seq_JUKART_Human | 1.19281703 |
| 94 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.18977665 |
| 95 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.18261132 |
| 96 | VDR_22108803_ChIP-Seq_LS180_Human | 1.17765757 |
| 97 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.17399199 |
| 98 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.15273771 |
| 99 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.14503256 |
| 100 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.14184159 |
| 101 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.14088830 |
| 102 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.14016785 |
| 103 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.11478780 |
| 104 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.11434834 |
| 105 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.11387131 |
| 106 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11354255 |
| 107 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10325255 |
| 108 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09597525 |
| 109 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.08783501 |
| 110 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.08762845 |
| 111 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.08530271 |
| 112 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07047811 |
| 113 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.06742458 |
| 114 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.06532845 |
| 115 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.06222641 |
| 116 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.05894295 |
| 117 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.05661082 |
| 118 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.05604418 |
| 119 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.05189448 |
| 120 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.04493321 |
| 121 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.04310064 |
| 122 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.03700484 |
| 123 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.03578035 |
| 124 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.03444859 |
| 125 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.02999493 |
| 126 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.02747800 |
| 127 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.01988301 |
| 128 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00912265 |
| 129 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.98472012 |
| 130 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.98362055 |
| 131 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98323379 |
| 132 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.98166113 |
| 133 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.96480853 |
| 134 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.94255120 |
| 135 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.93137058 |
| 136 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.93040149 |
| 137 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.93026888 |
| 138 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.93019693 |
| 139 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.93009550 |
| 140 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.92963418 |
| 141 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.92784887 |
| 142 | NCOR_22424771_ChIP-Seq_293T_Human | 0.92767798 |
| 143 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.92296776 |
| 144 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.91305810 |
| 145 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.91043429 |
| 146 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.91043429 |
| 147 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.90162010 |
| 148 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.89809307 |
| 149 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.89585641 |
| 150 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.89278078 |
| 151 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.88981449 |
| 152 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.88867650 |
| 153 | P300_19829295_ChIP-Seq_ESCs_Human | 0.88744839 |
| 154 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.88442772 |
| 155 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.87211525 |
| 156 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.83323877 |
| 157 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.82426495 |
| 158 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.81584210 |
| 159 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.80962291 |
| 160 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.80750627 |
| 161 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.79753844 |
| 162 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.78156343 |
| 163 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.77659158 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002132_abnormal_respiratory_system | 4.31958939 |
| 2 | MP0003880_abnormal_central_pattern | 3.76106585 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 3.10621165 |
| 4 | MP0001529_abnormal_vocalization | 2.73024308 |
| 5 | MP0004142_abnormal_muscle_tone | 2.68177868 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 2.64270917 |
| 7 | MP0005360_urolithiasis | 2.58284056 |
| 8 | MP0002736_abnormal_nociception_after | 2.45247914 |
| 9 | MP0004043_abnormal_pH_regulation | 2.42644208 |
| 10 | MP0002272_abnormal_nervous_system | 2.39407765 |
| 11 | MP0003436_decreased_susceptibility_to | 2.35748890 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.35576371 |
| 13 | MP0002064_seizures | 2.30514449 |
| 14 | MP0002837_dystrophic_cardiac_calcinosis | 2.29069021 |
| 15 | * MP0006036_abnormal_mitochondrial_physio | 2.27110718 |
| 16 | MP0002822_catalepsy | 2.25314309 |
| 17 | MP0006082_CNS_inflammation | 2.21210768 |
| 18 | MP0004859_abnormal_synaptic_plasticity | 2.11544401 |
| 19 | MP0001905_abnormal_dopamine_level | 2.11474677 |
| 20 | MP0009745_abnormal_behavioral_response | 2.09138793 |
| 21 | MP0009046_muscle_twitch | 2.08612268 |
| 22 | MP0008875_abnormal_xenobiotic_pharmacok | 2.05812359 |
| 23 | MP0003635_abnormal_synaptic_transmissio | 2.00738843 |
| 24 | MP0005085_abnormal_gallbladder_physiolo | 1.98183889 |
| 25 | MP0000013_abnormal_adipose_tissue | 1.97679793 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 1.95539534 |
| 27 | MP0002876_abnormal_thyroid_physiology | 1.94635313 |
| 28 | MP0006276_abnormal_autonomic_nervous | 1.92579064 |
| 29 | MP0006035_abnormal_mitochondrial_morpho | 1.90391328 |
| 30 | MP0005025_abnormal_response_to | 1.89154445 |
| 31 | MP0009785_altered_susceptibility_to | 1.85808972 |
| 32 | MP0005365_abnormal_bile_salt | 1.84792700 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.80479443 |
| 34 | MP0001835_abnormal_antigen_presentation | 1.79333245 |
| 35 | MP0002735_abnormal_chemical_nociception | 1.77602527 |
| 36 | MP0002572_abnormal_emotion/affect_behav | 1.76076241 |
| 37 | MP0003195_calcinosis | 1.75020534 |
| 38 | MP0003879_abnormal_hair_cell | 1.73636832 |
| 39 | MP0005000_abnormal_immune_tolerance | 1.72943282 |
| 40 | MP0002734_abnormal_mechanical_nocicepti | 1.71005693 |
| 41 | MP0001440_abnormal_grooming_behavior | 1.70919612 |
| 42 | MP0001986_abnormal_taste_sensitivity | 1.70016131 |
| 43 | MP0005671_abnormal_response_to | 1.67176466 |
| 44 | MP0001486_abnormal_startle_reflex | 1.64957256 |
| 45 | MP0002638_abnormal_pupillary_reflex | 1.64221665 |
| 46 | MP0001764_abnormal_homeostasis | 1.63108688 |
| 47 | MP0002254_reproductive_system_inflammat | 1.62522422 |
| 48 | MP0003329_amyloid_beta_deposits | 1.61921202 |
| 49 | MP0002163_abnormal_gland_morphology | 1.60698455 |
| 50 | MP0004270_analgesia | 1.60466212 |
| 51 | MP0001970_abnormal_pain_threshold | 1.60402101 |
| 52 | MP0002063_abnormal_learning/memory/cond | 1.59882192 |
| 53 | MP0000685_abnormal_immune_system | 1.58824336 |
| 54 | MP0005332_abnormal_amino_acid | 1.58663931 |
| 55 | MP0008469_abnormal_protein_level | 1.58155019 |
| 56 | MP0002419_abnormal_innate_immunity | 1.56935712 |
| 57 | MP0005423_abnormal_somatic_nervous | 1.56190013 |
| 58 | MP0001790_abnormal_immune_system | 1.55617497 |
| 59 | MP0005387_immune_system_phenotype | 1.55617497 |
| 60 | MP0000920_abnormal_myelination | 1.54622571 |
| 61 | MP0009379_abnormal_foot_pigmentation | 1.52061742 |
| 62 | MP0010386_abnormal_urinary_bladder | 1.50868342 |
| 63 | MP0002723_abnormal_immune_serum | 1.50187660 |
| 64 | MP0001845_abnormal_inflammatory_respons | 1.47839558 |
| 65 | MP0002067_abnormal_sensory_capabilities | 1.45421535 |
| 66 | MP0002733_abnormal_thermal_nociception | 1.44936176 |
| 67 | MP0010155_abnormal_intestine_physiology | 1.44154906 |
| 68 | MP0004147_increased_porphyrin_level | 1.42984018 |
| 69 | MP0003303_peritoneal_inflammation | 1.40970798 |
| 70 | MP0002693_abnormal_pancreas_physiology | 1.39244604 |
| 71 | MP0010329_abnormal_lipoprotein_level | 1.38881619 |
| 72 | MP0001984_abnormal_olfaction | 1.38639246 |
| 73 | MP0002653_abnormal_ependyma_morphology | 1.38438471 |
| 74 | MP0008260_abnormal_autophagy | 1.38264792 |
| 75 | MP0003724_increased_susceptibility_to | 1.36253803 |
| 76 | MP0001800_abnormal_humoral_immune | 1.35955318 |
| 77 | MP0001501_abnormal_sleep_pattern | 1.35344610 |
| 78 | MP0005464_abnormal_platelet_physiology | 1.34668687 |
| 79 | MP0003011_delayed_dark_adaptation | 1.33728345 |
| 80 | MP0005535_abnormal_body_temperature | 1.32253619 |
| 81 | MP0001502_abnormal_circadian_rhythm | 1.32225870 |
| 82 | MP0005083_abnormal_biliary_tract | 1.31451313 |
| 83 | MP0002420_abnormal_adaptive_immunity | 1.30628398 |
| 84 | MP0001819_abnormal_immune_cell | 1.29775736 |
| 85 | MP0005075_abnormal_melanosome_morpholog | 1.28972245 |
| 86 | MP0004510_myositis | 1.28015592 |
| 87 | MP0003075_altered_response_to | 1.27307107 |
| 88 | MP0002452_abnormal_antigen_presenting | 1.25096867 |
| 89 | MP0003191_abnormal_cellular_cholesterol | 1.24224089 |
| 90 | MP0003690_abnormal_glial_cell | 1.23701025 |
| 91 | MP0008872_abnormal_physiological_respon | 1.23589128 |
| 92 | MP0005386_behavior/neurological_phenoty | 1.23420667 |
| 93 | MP0004924_abnormal_behavior | 1.23420667 |
| 94 | MP0008569_lethality_at_weaning | 1.22254004 |
| 95 | MP0001545_abnormal_hematopoietic_system | 1.21756421 |
| 96 | MP0005397_hematopoietic_system_phenotyp | 1.21756421 |
| 97 | MP0005646_abnormal_pituitary_gland | 1.18759088 |
| 98 | MP0002229_neurodegeneration | 1.17563930 |
| 99 | MP0005084_abnormal_gallbladder_morpholo | 1.16402277 |
| 100 | MP0003186_abnormal_redox_activity | 1.15879755 |
| 101 | MP0000343_altered_response_to | 1.15314807 |
| 102 | MP0001666_abnormal_nutrient_absorption | 1.13273808 |
| 103 | MP0005636_abnormal_mineral_homeostasis | 1.13265019 |
| 104 | MP0000609_abnormal_liver_physiology | 1.09985601 |
| 105 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.08395989 |
| 106 | MP0001873_stomach_inflammation | 1.07777871 |
| 107 | MP0002909_abnormal_adrenal_gland | 1.07564597 |
| 108 | MP0003787_abnormal_imprinting | 1.07097008 |
| 109 | MP0002118_abnormal_lipid_homeostasis | 1.04480996 |
| 110 | MP0005058_abnormal_lysosome_morphology | 1.03834230 |
| 111 | MP0001188_hyperpigmentation | 1.03665829 |
| 112 | MP0002277_abnormal_respiratory_mucosa | 1.03087106 |
| 113 | MP0001533_abnormal_skeleton_physiology | 1.02526610 |
| 114 | MP0001944_abnormal_pancreas_morphology | 1.01570452 |
| 115 | MP0010234_abnormal_vibrissa_follicle | 1.01304896 |
| 116 | MP0003656_abnormal_erythrocyte_physiolo | 1.00914045 |
| 117 | MP0004947_skin_inflammation | 1.00489691 |
| 118 | MP0000716_abnormal_immune_system | 1.00001472 |
| 119 | MP0005551_abnormal_eye_electrophysiolog | 0.98892311 |
| 120 | MP0005451_abnormal_body_composition | 0.98120871 |
| 121 | MP0009764_decreased_sensitivity_to | 0.96603424 |
| 122 | MP0000230_abnormal_systemic_arterial | 0.96030007 |
| 123 | * MP0002066_abnormal_motor_capabilities/c | 0.95489515 |
| 124 | MP0000689_abnormal_spleen_morphology | 0.94945013 |
| 125 | MP0000604_amyloidosis | 0.94541299 |
| 126 | MP0003866_abnormal_defecation | 0.89985729 |
| 127 | MP0004185_abnormal_adipocyte_glucose | 0.89771070 |
| 128 | MP0002722_abnormal_immune_system | 0.86161841 |
| 129 | MP0000747_muscle_weakness | 0.86055222 |
| 130 | MP0001664_abnormal_digestion | 0.85676419 |
| 131 | MP0003633_abnormal_nervous_system | 0.85663127 |
| 132 | MP0009642_abnormal_blood_homeostasis | 0.83286186 |
| 133 | MP0001756_abnormal_urination | 0.83275479 |
| 134 | MP0005376_homeostasis/metabolism_phenot | 0.83179607 |
| 135 | MP0004742_abnormal_vestibular_system | 0.82399997 |
| 136 | MP0002429_abnormal_blood_cell | 0.82278170 |
| 137 | MP0002090_abnormal_vision | 0.81461585 |
| 138 | MP0000015_abnormal_ear_pigmentation | 0.80800703 |
| 139 | MP0009840_abnormal_foam_cell | 0.80747740 |
| 140 | MP0002557_abnormal_social/conspecific_i | 0.79867500 |
| 141 | MP0002405_respiratory_system_inflammati | 0.79622393 |
| 142 | MP0003172_abnormal_lysosome_physiology | 0.79307902 |
| 143 | MP0009643_abnormal_urine_homeostasis | 0.79208004 |
| 144 | MP0000490_abnormal_crypts_of | 0.78812341 |
| 145 | MP0002398_abnormal_bone_marrow | 0.78573686 |
| 146 | MP0005645_abnormal_hypothalamus_physiol | 0.78316506 |
| 147 | MP0005379_endocrine/exocrine_gland_phen | 0.77185530 |
| 148 | MP0003646_muscle_fatigue | 0.77170849 |
| 149 | MP0005319_abnormal_enzyme/_coenzyme | 0.76599098 |
| 150 | MP0004019_abnormal_vitamin_homeostasis | 0.74776592 |
| 151 | MP0003634_abnormal_glial_cell | 0.74690480 |
| 152 | MP0009780_abnormal_chondrocyte_physiolo | 0.74638336 |
| 153 | MP0001663_abnormal_digestive_system | 0.73811221 |
| 154 | MP0001765_abnormal_ion_homeostasis | 0.73171704 |
| 155 | MP0003183_abnormal_peptide_metabolism | 0.72488748 |
| 156 | MP0000358_abnormal_cell_content/ | 0.71858717 |
| 157 | MP0002078_abnormal_glucose_homeostasis | 0.70548663 |
| 158 | MP0004036_abnormal_muscle_relaxation | 0.70265664 |
| 159 | MP0003631_nervous_system_phenotype | 0.70258685 |
| 160 | * MP0008874_decreased_physiological_sensi | 0.70211219 |
| 161 | MP0001963_abnormal_hearing_physiology | 0.69941749 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 5.63319487 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.29000875 |
| 3 | Petechiae (HP:0000967) | 5.22206161 |
| 4 | Acute encephalopathy (HP:0006846) | 5.07852129 |
| 5 | * Mitochondrial inheritance (HP:0001427) | 4.96446220 |
| 6 | * Hepatocellular necrosis (HP:0001404) | 4.85659101 |
| 7 | Progressive macrocephaly (HP:0004481) | 4.65288097 |
| 8 | * Hepatic necrosis (HP:0002605) | 4.40612716 |
| 9 | * Increased CSF lactate (HP:0002490) | 4.34426758 |
| 10 | Cerebral edema (HP:0002181) | 3.95425786 |
| 11 | Increased serum pyruvate (HP:0003542) | 3.48388289 |
| 12 | Abnormality of glycolysis (HP:0004366) | 3.48388289 |
| 13 | Increased hepatocellular lipid droplets (HP:0006565) | 3.43695394 |
| 14 | Renal Fanconi syndrome (HP:0001994) | 3.41805954 |
| 15 | Lipid accumulation in hepatocytes (HP:0006561) | 3.39692671 |
| 16 | * Lactic acidosis (HP:0003128) | 3.37076866 |
| 17 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.28849846 |
| 18 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.28849846 |
| 19 | Leukodystrophy (HP:0002415) | 3.28159616 |
| 20 | Vacuolated lymphocytes (HP:0001922) | 3.26114850 |
| 21 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.19112649 |
| 22 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.18850796 |
| 23 | Increased intramyocellular lipid droplets (HP:0012240) | 3.14347646 |
| 24 | Abnormality of macrophages (HP:0004311) | 3.09897085 |
| 25 | * Respiratory failure (HP:0002878) | 3.06566205 |
| 26 | Dysostosis multiplex (HP:0000943) | 3.06167827 |
| 27 | Focal motor seizures (HP:0011153) | 3.02505448 |
| 28 | Pheochromocytoma (HP:0002666) | 3.01144846 |
| 29 | * Increased serum lactate (HP:0002151) | 3.00668540 |
| 30 | Increased muscle lipid content (HP:0009058) | 2.96911643 |
| 31 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.96794966 |
| 32 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.96794966 |
| 33 | Abnormality of glycolipid metabolism (HP:0010969) | 2.96794966 |
| 34 | Neuroendocrine neoplasm (HP:0100634) | 2.96231069 |
| 35 | Optic disc pallor (HP:0000543) | 2.94674509 |
| 36 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.91169368 |
| 37 | 3-Methylglutaconic aciduria (HP:0003535) | 2.82431490 |
| 38 | Myokymia (HP:0002411) | 2.81565310 |
| 39 | Lethargy (HP:0001254) | 2.74058085 |
| 40 | Exercise intolerance (HP:0003546) | 2.72884335 |
| 41 | Increased cerebral lipofuscin (HP:0011813) | 2.71715332 |
| 42 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.62143007 |
| 43 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.61599990 |
| 44 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.61599990 |
| 45 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.61599990 |
| 46 | Limb dystonia (HP:0002451) | 2.59127460 |
| 47 | Generalized aminoaciduria (HP:0002909) | 2.55695733 |
| 48 | Methylmalonic acidemia (HP:0002912) | 2.55283817 |
| 49 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.55143828 |
| 50 | Mucopolysacchariduria (HP:0008155) | 2.55143828 |
| 51 | * CNS demyelination (HP:0007305) | 2.52519493 |
| 52 | Increased serum ferritin (HP:0003281) | 2.47469083 |
| 53 | Abnormality of dental color (HP:0011073) | 2.47368834 |
| 54 | Short middle phalanx of the 5th finger (HP:0004220) | 2.46204005 |
| 55 | Methylmalonic aciduria (HP:0012120) | 2.44929513 |
| 56 | Eczematoid dermatitis (HP:0000976) | 2.43093177 |
| 57 | Systemic lupus erythematosus (HP:0002725) | 2.40762922 |
| 58 | Prolonged neonatal jaundice (HP:0006579) | 2.40602148 |
| 59 | Loss of speech (HP:0002371) | 2.39007709 |
| 60 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.36556488 |
| 61 | Dicarboxylic aciduria (HP:0003215) | 2.36556488 |
| 62 | Progressive neurologic deterioration (HP:0002344) | 2.35240977 |
| 63 | Acanthocytosis (HP:0001927) | 2.34965224 |
| 64 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.31633399 |
| 65 | Cerebral hemorrhage (HP:0001342) | 2.31246291 |
| 66 | Atonic seizures (HP:0010819) | 2.31096053 |
| 67 | Testicular atrophy (HP:0000029) | 2.30687321 |
| 68 | Xanthomatosis (HP:0000991) | 2.30093271 |
| 69 | Hypobetalipoproteinemia (HP:0003563) | 2.29896545 |
| 70 | Prolonged partial thromboplastin time (HP:0003645) | 2.26484762 |
| 71 | Hypothermia (HP:0002045) | 2.26129951 |
| 72 | Brushfield spots (HP:0001088) | 2.24328800 |
| 73 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.23738350 |
| 74 | Abnormality of renal resorption (HP:0011038) | 2.23047710 |
| 75 | Failure to thrive in infancy (HP:0001531) | 2.22851153 |
| 76 | Recurrent abscess formation (HP:0002722) | 2.22198513 |
| 77 | Recurrent bacterial skin infections (HP:0005406) | 2.19279062 |
| 78 | Abnormality of iron homeostasis (HP:0011031) | 2.19247449 |
| 79 | Vomiting (HP:0002013) | 2.17721724 |
| 80 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.16958656 |
| 81 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.16892472 |
| 82 | Hyperventilation (HP:0002883) | 2.16030423 |
| 83 | Congenital malformation of the right heart (HP:0011723) | 2.14075081 |
| 84 | Double outlet right ventricle (HP:0001719) | 2.14075081 |
| 85 | Intrahepatic cholestasis (HP:0001406) | 2.12445453 |
| 86 | Progressive inability to walk (HP:0002505) | 2.10323436 |
| 87 | Conjugated hyperbilirubinemia (HP:0002908) | 2.10275449 |
| 88 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.09141419 |
| 89 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.08613973 |
| 90 | Glycosuria (HP:0003076) | 2.07776599 |
| 91 | Abnormality of urine glucose concentration (HP:0011016) | 2.07776599 |
| 92 | Exertional dyspnea (HP:0002875) | 2.07654212 |
| 93 | Tongue fasciculations (HP:0001308) | 2.06380614 |
| 94 | Chronic obstructive pulmonary disease (HP:0006510) | 2.05811730 |
| 95 | Obstructive lung disease (HP:0006536) | 2.05811730 |
| 96 | Purpura (HP:0000979) | 2.04836580 |
| 97 | * Emotional lability (HP:0000712) | 2.04031188 |
| 98 | Prolonged bleeding time (HP:0003010) | 2.03869327 |
| 99 | Ketosis (HP:0001946) | 2.03392526 |
| 100 | Respiratory difficulties (HP:0002880) | 2.02283345 |
| 101 | Poor suck (HP:0002033) | 2.01503587 |
| 102 | Hyperglycinemia (HP:0002154) | 2.00771924 |
| 103 | X-linked dominant inheritance (HP:0001423) | 1.98446141 |
| 104 | Retinal dysplasia (HP:0007973) | 1.98111194 |
| 105 | Opisthotonus (HP:0002179) | 1.97529715 |
| 106 | Abnormal number of erythroid precursors (HP:0012131) | 1.97484360 |
| 107 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.96752636 |
| 108 | Cholecystitis (HP:0001082) | 1.96516277 |
| 109 | Abnormal gallbladder physiology (HP:0012438) | 1.96516277 |
| 110 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.96196485 |
| 111 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.96196485 |
| 112 | Abnormal protein glycosylation (HP:0012346) | 1.96196485 |
| 113 | Abnormal glycosylation (HP:0012345) | 1.96196485 |
| 114 | Microvesicular hepatic steatosis (HP:0001414) | 1.93212044 |
| 115 | Cerebral hypomyelination (HP:0006808) | 1.93135495 |
| 116 | Muscle fibrillation (HP:0010546) | 1.93048242 |
| 117 | Cerebral palsy (HP:0100021) | 1.92638263 |
| 118 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.91151624 |
| 119 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.91151624 |
| 120 | Focal dystonia (HP:0004373) | 1.90880507 |
| 121 | Ragged-red muscle fibers (HP:0003200) | 1.89360617 |
| 122 | Spastic paraparesis (HP:0002313) | 1.88101072 |
| 123 | Type I transferrin isoform profile (HP:0003642) | 1.88092184 |
| 124 | Reticulocytosis (HP:0001923) | 1.87932642 |
| 125 | Hypokinesia (HP:0002375) | 1.86452297 |
| 126 | Hyperammonemia (HP:0001987) | 1.85850384 |
| 127 | Hepatosplenomegaly (HP:0001433) | 1.85222011 |
| 128 | J-shaped sella turcica (HP:0002680) | 1.84755203 |
| 129 | * Gliosis (HP:0002171) | 1.83586181 |
| 130 | Absence seizures (HP:0002121) | 1.83507956 |
| 131 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.83483259 |
| 132 | Abnormality of alanine metabolism (HP:0010916) | 1.83483259 |
| 133 | Hyperalaninemia (HP:0003348) | 1.83483259 |
| 134 | Abnormality of glycine metabolism (HP:0010895) | 1.82784310 |
| 135 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.82784310 |
| 136 | Abnormal pupillary function (HP:0007686) | 1.81050262 |
| 137 | Hyperphosphaturia (HP:0003109) | 1.80805012 |
| 138 | Metabolic acidosis (HP:0001942) | 1.80667575 |
| 139 | Hyperthyroidism (HP:0000836) | 1.79884453 |
| 140 | Stomatitis (HP:0010280) | 1.79763531 |
| 141 | Hyperlipoproteinemia (HP:0010980) | 1.79465026 |
| 142 | Epileptic encephalopathy (HP:0200134) | 1.79261072 |
| 143 | Medial flaring of the eyebrow (HP:0010747) | 1.78739577 |
| 144 | Myositis (HP:0100614) | 1.78445036 |
| 145 | Neurofibrillary tangles (HP:0002185) | 1.77452820 |
| 146 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.76521354 |
| 147 | Parakeratosis (HP:0001036) | 1.75911335 |
| 148 | Abnormal platelet function (HP:0011869) | 1.75082922 |
| 149 | Impaired platelet aggregation (HP:0003540) | 1.75082922 |
| 150 | Deep palmar crease (HP:0006191) | 1.74905563 |
| 151 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.74429792 |
| 152 | Abnormal hair whorl (HP:0010721) | 1.73071084 |
| 153 | Polyphagia (HP:0002591) | 1.72969675 |
| 154 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.72657709 |
| 155 | Dialeptic seizures (HP:0011146) | 1.72654585 |
| 156 | Oligomenorrhea (HP:0000876) | 1.72124977 |
| 157 | Anxiety (HP:0000739) | 1.70919555 |
| 158 | Gait imbalance (HP:0002141) | 1.69863281 |
| 159 | Epiphyseal stippling (HP:0010655) | 1.69626922 |
| 160 | Gout (HP:0001997) | 1.67925124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.47876231 |
| 2 | MAP3K12 | 3.98825204 |
| 3 | ARAF | 3.66290560 |
| 4 | CASK | 3.27845601 |
| 5 | STK16 | 2.69324877 |
| 6 | TESK1 | 2.64684788 |
| 7 | CDK19 | 2.50086770 |
| 8 | OXSR1 | 2.38801712 |
| 9 | BRAF | 2.33018686 |
| 10 | VRK2 | 2.26230624 |
| 11 | MYLK | 2.25398874 |
| 12 | BCKDK | 2.04975086 |
| 13 | STK39 | 1.97543254 |
| 14 | PRPF4B | 1.95636244 |
| 15 | MAP2K7 | 1.94692658 |
| 16 | TNIK | 1.94063457 |
| 17 | TBK1 | 1.88340779 |
| 18 | MAP4K1 | 1.83526910 |
| 19 | EPHA4 | 1.81714356 |
| 20 | BMPR1B | 1.80331583 |
| 21 | NME1 | 1.77467576 |
| 22 | MST4 | 1.72519707 |
| 23 | TYK2 | 1.69835334 |
| 24 | IRAK3 | 1.68500543 |
| 25 | AKT3 | 1.56889205 |
| 26 | PIM2 | 1.56788409 |
| 27 | MAPKAPK5 | 1.48932632 |
| 28 | IRAK4 | 1.46801138 |
| 29 | GRK5 | 1.43365097 |
| 30 | TRIB3 | 1.41341822 |
| 31 | BLK | 1.40236166 |
| 32 | PINK1 | 1.39412396 |
| 33 | MAP2K4 | 1.38775199 |
| 34 | TAOK2 | 1.37374024 |
| 35 | TAOK1 | 1.36452170 |
| 36 | MAP3K4 | 1.34064850 |
| 37 | SIK2 | 1.32825261 |
| 38 | EPHB1 | 1.31896610 |
| 39 | ZAP70 | 1.31378217 |
| 40 | GRK7 | 1.30053246 |
| 41 | GRK6 | 1.28092615 |
| 42 | PIK3CA | 1.27667644 |
| 43 | MAPKAPK3 | 1.25708699 |
| 44 | NTRK3 | 1.24735556 |
| 45 | MAP3K1 | 1.24031404 |
| 46 | CAMK2B | 1.23933628 |
| 47 | KDR | 1.20028528 |
| 48 | DAPK2 | 1.19029574 |
| 49 | MAP2K3 | 1.18610864 |
| 50 | NME2 | 1.16762500 |
| 51 | SIK1 | 1.15755923 |
| 52 | CAMK2G | 1.14284646 |
| 53 | LRRK2 | 1.12969592 |
| 54 | IKBKB | 1.12883590 |
| 55 | MUSK | 1.12783542 |
| 56 | ADRBK2 | 1.12448163 |
| 57 | MAP3K9 | 1.11222067 |
| 58 | SIK3 | 1.09881420 |
| 59 | PDK2 | 1.09631851 |
| 60 | LIMK1 | 1.09418490 |
| 61 | PHKG2 | 1.06173934 |
| 62 | PHKG1 | 1.06173934 |
| 63 | DAPK1 | 1.05453884 |
| 64 | DAPK3 | 1.04649809 |
| 65 | WNK4 | 1.01748560 |
| 66 | NEK6 | 1.00816452 |
| 67 | MAP3K3 | 1.00132092 |
| 68 | BMPR2 | 0.95073205 |
| 69 | GRK1 | 0.94603872 |
| 70 | VRK1 | 0.93115311 |
| 71 | CAMK2D | 0.92730781 |
| 72 | PRKCI | 0.91093688 |
| 73 | BCR | 0.90287718 |
| 74 | CSNK1G3 | 0.89165308 |
| 75 | SMG1 | 0.88524322 |
| 76 | CAMK2A | 0.88264542 |
| 77 | ABL2 | 0.87136446 |
| 78 | IKBKE | 0.86353884 |
| 79 | EIF2AK3 | 0.85883402 |
| 80 | TLK1 | 0.85384719 |
| 81 | MINK1 | 0.82900273 |
| 82 | CDK5 | 0.81767645 |
| 83 | MAPK13 | 0.81473208 |
| 84 | SGK223 | 0.79032840 |
| 85 | SGK494 | 0.79032840 |
| 86 | SRPK1 | 0.78603594 |
| 87 | PRKCG | 0.78388198 |
| 88 | PRKD3 | 0.77690042 |
| 89 | RIPK4 | 0.77472902 |
| 90 | PDPK1 | 0.77324292 |
| 91 | TESK2 | 0.77265201 |
| 92 | TXK | 0.77178442 |
| 93 | MAP4K2 | 0.73439620 |
| 94 | PLK2 | 0.72533268 |
| 95 | TSSK6 | 0.71475974 |
| 96 | CAMKK2 | 0.71070709 |
| 97 | KIT | 0.70620256 |
| 98 | MAP3K13 | 0.70241738 |
| 99 | CSK | 0.68735921 |
| 100 | MAP2K6 | 0.68543661 |
| 101 | CCNB1 | 0.68296769 |
| 102 | CSNK1G2 | 0.65683515 |
| 103 | PDK3 | 0.65613053 |
| 104 | PDK4 | 0.65613053 |
| 105 | LYN | 0.63275412 |
| 106 | CDK18 | 0.62573418 |
| 107 | RAF1 | 0.62506879 |
| 108 | ADRBK1 | 0.62487703 |
| 109 | CDK11A | 0.62086783 |
| 110 | CDK15 | 0.61058753 |
| 111 | TNK2 | 0.60785727 |
| 112 | TEC | 0.60551432 |
| 113 | PRKCE | 0.60183258 |
| 114 | CDK14 | 0.59897451 |
| 115 | ZAK | 0.57945731 |
| 116 | PRKD2 | 0.57393719 |
| 117 | DYRK3 | 0.56918534 |
| 118 | MAPK12 | 0.55635423 |
| 119 | MATK | 0.53122190 |
| 120 | PRKACA | 0.52352553 |
| 121 | ILK | 0.51845701 |
| 122 | PDK1 | 0.50880420 |
| 123 | PAK4 | 0.50698667 |
| 124 | FES | 0.50347126 |
| 125 | SYK | 0.49483138 |
| 126 | EIF2AK1 | 0.48553536 |
| 127 | UHMK1 | 0.48209992 |
| 128 | ROCK2 | 0.47655265 |
| 129 | STK24 | 0.47077617 |
| 130 | PRKD1 | 0.46874192 |
| 131 | NTRK1 | 0.45992569 |
| 132 | PKN2 | 0.44957727 |
| 133 | CSNK1G1 | 0.44829849 |
| 134 | BTK | 0.44476004 |
| 135 | AURKA | 0.44131294 |
| 136 | FGR | 0.43783219 |
| 137 | EPHA2 | 0.43583232 |
| 138 | PKN1 | 0.42545257 |
| 139 | MAP3K11 | 0.41522584 |
| 140 | OBSCN | 0.40994999 |
| 141 | LCK | 0.40340694 |
| 142 | PASK | 0.40187541 |
| 143 | HIPK2 | 0.39678595 |
| 144 | MARK2 | 0.39572710 |
| 145 | PRKCA | 0.39542964 |
| 146 | PNCK | 0.39507183 |
| 147 | PRKCD | 0.38619933 |
| 148 | NEK9 | 0.38357402 |
| 149 | PRKCQ | 0.38352401 |
| 150 | CDK8 | 0.38348826 |
| 151 | IRAK2 | 0.38287123 |
| 152 | MAPK11 | 0.35884785 |
| 153 | DYRK1B | 0.34067477 |
| 154 | CAMK1 | 0.33333241 |
| 155 | CSNK1A1L | 0.33209784 |
| 156 | ITK | 0.32564076 |
| 157 | BMX | 0.31342258 |
| 158 | PAK1 | 0.31327978 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.67856338 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 3.78512680 |
| 3 | Alzheimers disease_Homo sapiens_hsa05010 | 2.84698875 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.67792312 |
| 5 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.66027271 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.51437789 |
| 7 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.39857780 |
| 8 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.34560441 |
| 9 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.34276999 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.29597481 |
| 11 | Huntingtons disease_Homo sapiens_hsa05016 | 2.26195528 |
| 12 | Proteasome_Homo sapiens_hsa03050 | 2.13078859 |
| 13 | Protein export_Homo sapiens_hsa03060 | 2.08730327 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.05972411 |
| 15 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.97377992 |
| 16 | Lysosome_Homo sapiens_hsa04142 | 1.97224745 |
| 17 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.96143629 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.86049887 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.80151838 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.75669930 |
| 21 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.74893367 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.72119596 |
| 23 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.71705174 |
| 24 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.65828709 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.65790684 |
| 26 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.64912379 |
| 27 | Nicotine addiction_Homo sapiens_hsa05033 | 1.57684041 |
| 28 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.55574715 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.52864654 |
| 30 | Ribosome_Homo sapiens_hsa03010 | 1.51466609 |
| 31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.42685873 |
| 32 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.40150017 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.40098297 |
| 34 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.38296179 |
| 35 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.34417237 |
| 36 | Histidine metabolism_Homo sapiens_hsa00340 | 1.32680924 |
| 37 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.32229409 |
| 38 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.28186143 |
| 39 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.27728056 |
| 40 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.25949122 |
| 41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.22324918 |
| 42 | Galactose metabolism_Homo sapiens_hsa00052 | 1.21457944 |
| 43 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.19267411 |
| 44 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.18971634 |
| 45 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.13005476 |
| 46 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.11579366 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10835741 |
| 48 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.10061211 |
| 49 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.08307887 |
| 50 | RNA polymerase_Homo sapiens_hsa03020 | 1.04335234 |
| 51 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.03089444 |
| 52 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.02354283 |
| 53 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.00201288 |
| 54 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.99352292 |
| 55 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.97381554 |
| 56 | GABAergic synapse_Homo sapiens_hsa04727 | 0.97131413 |
| 57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.96334416 |
| 58 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.95756577 |
| 59 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.95235632 |
| 60 | Metabolic pathways_Homo sapiens_hsa01100 | 0.94996213 |
| 61 | Allograft rejection_Homo sapiens_hsa05330 | 0.91862398 |
| 62 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.90399848 |
| 63 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.86781255 |
| 64 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.86662386 |
| 65 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.86121177 |
| 66 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.84401617 |
| 67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.82297538 |
| 68 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.81343436 |
| 69 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.79273791 |
| 70 | Salmonella infection_Homo sapiens_hsa05132 | 0.78384905 |
| 71 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.78079717 |
| 72 | Sulfur relay system_Homo sapiens_hsa04122 | 0.77989687 |
| 73 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.77463942 |
| 74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.77070807 |
| 75 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.74694253 |
| 76 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.72678810 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72121934 |
| 78 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.71781923 |
| 79 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.67561375 |
| 80 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.66543772 |
| 81 | Legionellosis_Homo sapiens_hsa05134 | 0.66355320 |
| 82 | Morphine addiction_Homo sapiens_hsa05032 | 0.66066064 |
| 83 | Mineral absorption_Homo sapiens_hsa04978 | 0.64138546 |
| 84 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.63607071 |
| 85 | Base excision repair_Homo sapiens_hsa03410 | 0.61520510 |
| 86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60308978 |
| 87 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.60229515 |
| 88 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.59757882 |
| 89 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.58787412 |
| 90 | Olfactory transduction_Homo sapiens_hsa04740 | 0.56564512 |
| 91 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.56315659 |
| 92 | Tuberculosis_Homo sapiens_hsa05152 | 0.55686850 |
| 93 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.55188561 |
| 94 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.53019836 |
| 95 | Retinol metabolism_Homo sapiens_hsa00830 | 0.52978569 |
| 96 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52577808 |
| 97 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.52133038 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51777224 |
| 99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.50904454 |
| 100 | Shigellosis_Homo sapiens_hsa05131 | 0.50750897 |
| 101 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50119693 |
| 102 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.49092922 |
| 103 | Circadian entrainment_Homo sapiens_hsa04713 | 0.47996913 |
| 104 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.47784025 |
| 105 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.47618766 |
| 106 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.47491799 |
| 107 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.47435911 |
| 108 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.46248825 |
| 109 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.46001912 |
| 110 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.45750629 |
| 111 | Taste transduction_Homo sapiens_hsa04742 | 0.44896743 |
| 112 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.44185846 |
| 113 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.43659658 |
| 114 | Asthma_Homo sapiens_hsa05310 | 0.43418506 |
| 115 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.43262728 |
| 116 | ABC transporters_Homo sapiens_hsa02010 | 0.43229222 |
| 117 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.43033696 |
| 118 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.43017730 |
| 119 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.42781079 |
| 120 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.42294127 |
| 121 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.41997374 |
| 122 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40275527 |
| 123 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.39318126 |
| 124 | Phagosome_Homo sapiens_hsa04145 | 0.36531804 |
| 125 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.34799927 |
| 126 | Insulin secretion_Homo sapiens_hsa04911 | 0.34624664 |
| 127 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32546637 |
| 128 | Salivary secretion_Homo sapiens_hsa04970 | 0.31772880 |
| 129 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.30941212 |

